Sars2 - seryl-tRNA synthetase 2, mitochondrial Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 292759
Summary
Predicted to enable serine-tRNA Ligase activity and tRNA binding activity. Predicted to be involved in mitochondrial seryl-tRNA aminoacylation. Predicted to be active in mitochondrion. Orthologous to human SARS2 (seryl-tRNA synthetase 2, mitochondrial). [provided by Alliance of Genome Resources, Apr 2022]
Sars2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001106240.1 | NP_001099710.1 | serine--tRNA ligase, mitochondrial |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
serine--tRNA ligase, mitochondrial |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-108325 | Brequinar | Inhibitor | 99.94% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS12449 | SARS2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-108325S | Brequinar-d3 | Inhibitor | / | Unkown |
| HY-180129 | SARS-CoV-2-IN-120 | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990814 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope B, SARS2-34) | Inhibitor | / | Unkown |
| HY-P990815 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope A, SARS2-01) | Inhibitor | / | Unkown |
| HY-P990816 | Anti-SARS-CoV-2 S protein Antibody (NTD, SARS2-29) | Inhibitor | / | Unkown |
| HY-P991763 | Anti-SARS-CoV-2 S protein (RBD) Antibody (SARS2-38) | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service